DEVELOPMENT AND VALIDATION OF CARBAMAZEPINE PLASMA CONCENTRATIONS MEASUREMENT AND ITS APPLICATION ON EPILEPSY PATIENTS
Keywords:Carbamazepine plasma concentration, HPLC, Validation, Epilepsy patients, Monotherapy or polytherapy
Objective: To develop and validate high-performance liquid chromatography with photodiode array (HPLC-PDA) detector as a method for measuring carbamazepine plasma concentrations in epilepsy patients treated with monotherapy or polytherapy.
Methods: Carbamazepine was extracted from epilepsy patients' plasma through liquid-liquid extraction, using protein precipitation with chloroform. Analysis was performed using HPLC with Inertsil DS-4 C18 (4.6x150 mm), 5 Î¼m particle size column. The optimal condition for separation was established in a mobile phase consisting of acetonitrile: water (50:50) at a flow rate of 1.0 ml/min, detected by PDA detector at 220 nm. Propylparaben was used as the internal standard. The retention time was 3.5 min.
Results: Linearity was obtained over a concentration range of 0.5-16 Î¼g/ml with r = 0.999. The method showed good intra-and inter-day precision and accuracy of more than 90% difference (% diff) and 95% relative standard deviation (RSD). Lower limit of quantification (LOQ) was 0.5 Î¼g/ml and lower limit of detection (LOD) was 0.2 Î¼g/ml with 100% accuracy and more than 90% precision. Recovery test was nearly 100%. Stability of carbamazepine plasma concentration in 3 epilepsy patients was measured on the first and third month of treatment, ranging between 83.5 to 98.7%. When used to compare carbamazepine as a monotherapy versus polytherapy, the method showed good selectivity.
Conclusion: The present HPLC method was valid for measuring carbamazepine plasma concentrations in epilepsy patients treated with monotherapy or polytherapy. This method meets the standard in the EMEA guideline in terms of linearity, precision, and accuracy, also selectivity in epilepsy patients treated with polytherapy.
Datar PA. Quantitative bio analytical and analytical method development of dibenzazepine derivative, carbamazepine: a review. JPA 2015;5:213-22.
Ezzeldin E, Shahat AA, Basudan OA. Development and validation of an HPLC method for the determination of carbamazepine in human plasma. Life Sci J 2013;10:2159-63.
Queiroz RHC, Bertucci C, Malfara WR, Dreossi SAC, Chaves AR, Valerio DAL, et al. Quantification of carbamazepine, carbamazepine-10,11-epoxide, phenytoin and phenobarbital in plasma samples by stir bar-sorptive extraction and liquid chromatography. J Pharm Biomed Anal 2008;48:428-34.
Dzodic P, Zavanovic L, Protic A, Ivanovic I, Velickovic-Radovanovic R, Spasic M, et al. Development and validation of a solid phase extraction-HPLC method for the determination of carbamazepine and its metabolites, carbamazepine epoxide and carbamazepine trans-diol, in plasma. J Serb Chem Soc 2012;77:1423-36.
Serralheiro A, Alves G, Fortuna A, Rocha M, Falcao A. First HPLC-UV method for rapid and simultaneous quantification of phenobarbital, primidone, phenytoin, carbamazepine, carbamazepine-10,11-epoxide. J Chromatogr B 2013;925:1-9.
Demirkaya F, Kadioglu Y. Determination of carbamazepine using RP-HPLC method in pharmaceutical preparations. FABAD J Pharm Sci 2005;30;78-82.
European Medicines Agency. Guideline on bio analytical method validation. United Kingdom: European Medicines Agency; 2011.
Tolou-Ghamari Z, Zare M, Habibabadi JM, Najafi MZ. A quick review of carbamazepine pharmacokinetics in epilepsy. J Res Med Sci 2013:Suppl 1:S81-5.
Center for Drug Evaluation and Research (U. S.), Center for Biologics Evaluation and Research (U. S.), and International Conference on Harmonisation. Guidance for industry: Q2B validation of analytical procedures, methodology. Maryland: U. S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; 1996.
Zadbuke N, Shahi S, Jadhav A, Borde S. Development and validation of a UV-visible spectroscopic method for estimation of carbamazepine in bulk and tablet dosage form. Int J Pharm Pharm Sci 2016;8:234-8.
Tonic-Ribarska J, Sterjev Z, Cvetkosvska E, Kuzmanovski I, Kiteva G, Suturkova L, et al. Optimization and validation of a bioanalytical SPE-HPLC method for the simultaneous determination of carbamazepine and its main metabolite, carbamazepine-10, 11-epoxide, in plasma. Macedonian Pharm Bull 2011;57:53-61.
Acharya M, AK J, Garud N. Stability indicating reversed phase-high performance liquid chromatography method development and validation for simultaneous determination of related substances of citicoline and piracetam in pharmaceutical dosage form. Asian J Pharm Clin Res 2016;9:292-7.
Yunoos M, Sankar G. A validated stability indicating a high-performance liquid chromatographic method for simultaneous determination of metformin HCL and dapaglifozin in bulk drug and tablet dosage form. Asian J Pharm Clin Res 2015;8:320-6.
Ghafghazi S, Zanjani TM, Vosough M, Sabetkasaei M. Interference-free determination of carbamazepine in human serum using high-performance liquid chromatography: a comprehensive research with three-way calibration methods. Int J Pharmacol Res 2017;16:120-31.